Delphine Lemoine

Regulatory affairs project manager at Dreem
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
FR
Languages
  • anglais Full professional proficiency
  • Espagnol Elementary proficiency
  • Français Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • France
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Regulatory affairs project manager
      • Jan 2022 - Present

      - Collaborate with cross-functional teams such as R&D, Quality, Product, and Legal to ensure that the design and development activities are performed according to the regulatory strategy and regulatory requirements (regulations and guidelines) - Overseeing the planning, coordination, and management of regulatory submission/documentation activities, for new products and/or product changes, to ensure timely approvals while in compliance with applicable requirements and regulations - Review and interpret relevant regulations, standards, and guidelines - Be involved and support R&D team activities related to design and development. - Provide feedback and on-going support to the R&D and Product teams to resolve usability issues related to the medical device, and questions from regulatory agencies - Stay up-to-date on changes to regulatory requirements and provide guidance to internal teams - Be involved in the company in interactions with regulatory agencies, such as audits, inspections and negotiations - Update local databases and registrations following marketing approval - Assist quality manager on quality activities related to design and development/technical files, including change control activities - Participate in risk management activities related to regulatory compliance Show less

    • France
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Lead Product Engineer
      • Sep 2016 - Jan 2022

       Industrialization process leader on the Retinal Implant Set: o Cleaning and assembly of the non-sterile set o Design transfer leader, weekly call  Production leader of the Retinal Implant Set o Weekly call of the implant semiconductor manufacturing process, routine and process development o Management of the chip production before cleaning and assembly o Management of the non-sterile and sterile Retinal Implant Set production o Support to clinical team : system improvement, surgeon training  Management and constant improvement of in vitro lifetime tests of subretinal PRIMA implants (scientific paper https://doi.org/10.1088/1741-2552/ab8f70): o Continuous monitoring and management of complex study involving multiple set-ups and tests over a long period of time o Opto-electronics testing to assess the electrical performance of the implant o Lifetime data analysis with Weibull++ software  Leader Qualification and validation studies related to Retinal Implant Set o Cleaning validation process, biocompatibility o Stability study, shelf-life, sterilization process validation o MRI compatibility per ISO/TS 10974  Team management (technicians): team trainings, planning management  Work in a strict quality system in conformity with regulatory requirements of active implantable medical devices, ISO 13485  Strong commitment: support to Quality and Regulatory team, laboratory responsible, chemical safety and ESD responsible, member of Covid task force team Show less

    • Ingénieur assistant (internship)
      • Feb 2016 - Jul 2016

    • Etudiant
      • Sep 2013 - Jul 2016

    • Sweden
    • Higher Education
    • 700 & Above Employee
    • Intern in Materials and Medicine
      • May 2015 - Jul 2015

      Developing a biphasic calcium phosphate cement (CPC) with increased degradation rate. It mainly consisted in designing and characterizing new low temperature self-setting multiphasic CPCs with increased degradation rate. All CPCs are obtained by mixing water or aqueous solution with blends of alpha-TCP, MCPM and beta-TCP at different molar ration. Developing a biphasic calcium phosphate cement (CPC) with increased degradation rate. It mainly consisted in designing and characterizing new low temperature self-setting multiphasic CPCs with increased degradation rate. All CPCs are obtained by mixing water or aqueous solution with blends of alpha-TCP, MCPM and beta-TCP at different molar ration.

    • France
    • Chemical Manufacturing
    • 700 & Above Employee
    • stagiaire
      • Jun 2014 - Jul 2014

Education

  • Grenoble INP - Phelma
    2013 - 2016

Community

You need to have a working account to view this content. Click here to join now